ARK Genomic Revolution ETF vs Kraft Heinz Co — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Kraft Heinz Co trades at $24.68 (market cap $29.23B). The key difference: Kraft Heinz Co pays a 6.49% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Kraft Heinz Co nearer its low. Which is the better fit depends on your goals.
| ARKG | KHC | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $44.55 | $28.06 |
52-Week Low | $24.02 | $21.21 |
Market Cap | — | $29.23B |
Enterprise Value | — | $45.55B |
Dividend Yield | — | 6.49% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →